Purpose Following curative treatment for localised renal cell carcinoma (RCC), up to 30% of
patients develop tumour recurrence. Prognostic scores are essential to guide individualised …

Simple Summary The aim of the present review is to discuss novel prognostic and
therapeutic markers for clear cell renal cell carcinoma, a subtype of renal cell carcinoma …

Simple Summary Approximately one fifth of patients with newly diagnosed renal cell
carcinoma (RCC) present with metastatic disease and over one third of the remaining …

METHODS: Talin-1 protein was demonstrated as a potential prognostic marker in renal cell
carcinoma (RCC) using bioinformatics analysis. We, therefore, examined the protein …

Introduction Lymph-vascular invasion (LVI) is recognized as an adverse pathological feature
in patients with renal cell carcinoma (RCC). However, its impact on overall survival (OS) is …

Background Clear cell renal cell carcinoma (ccRCC) is one of the most frequent
malignancies; however, the present prognostic factors was deficient. This study aims to …

After surgery of localized renal cell carcinoma, over 20% of the patients will develop distant
metastases. Our aim was to develop an easy-to-use prognostic model for predicting …

hydroxymethylcytosine (5hmC) is converted from DNA methylation of cytosine (5mC) by the
catalysis of TET proteins, and proposed to be involved in tumorigenesis. However, the …

Purpose We aimed to develop and externally validate a CT-based deep learning radiomics
model for predicting overall survival (OS) in clear cell renal cell carcinoma (ccRCC) patients …

This study aimed to compare the cancer-specific survival (CSS) and overall survival (OS) of
nephrectomized patients with non-metastatic renal cell carcinoma (nmRCC) and local …